Tag Archives: Forbes

FDA Approves First Muscular Dystrophy Drug Despite Thumbs Down by Scientific Panel

Federal regulators granted tentative approval to the first drug for muscular dystrophy, following an intense public campaign from patients and doctors who pushed for the largely unproven medication. The approval… Read more »

Theranos Pulls Zika Test from FDA Review after Problems Flagged; Anyone Else Hear a Death Knell?

Blood-testing firm Theranos Inc. (Palo Alto CA) said it voluntarily withdrew a request to the U.S. Food and Drug Administration for emergency clearance of its new Zika-virus blood test. Theranos… Read more »

DEA Ignores the Evidence; Keeps Marijuana on Parity with Heroin

In a long-awaited announcement, the U.S. Drug Enforcement Administration denied requests to loosen the classification of marijuana as a dangerous drug with no medical use. The decision, reported by Reuters,… Read more »

What Brexit Means for the UK’s National Health Service; What We Americans Might Learn

The United Kingdom’s decision to leave the European Union registered a magnitude 9 on the Richter scale across the world as far as I can judge. The economic fallout is… Read more »